Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Endocrine

• Publication date

  2018-08-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12020-018-1689-yPMID 30117113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Berberine Inhibits Oxygen Consumption Rate Independent of Alteration in Cardiolipin Levels in H9c2 Cells

  2017cited by this paper
• Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells.

  2016cited by this paper
• Glucagon therapeutics: Dawn of a new era for diabetes care

  2016cited by this paper
• Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective

  2016cited by this paper
• CRTC2 Is a Coactivator of GR and Couples GR and CREB in the Regulation of Hepatic Gluconeogenesis.

  2016cited by this paper
• Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway

  2015cited by this paper
• Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α

  2015cited by this paper
• Supplemental Figure 1

  2014cited by this paper
• Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine

  2014cited by this paper
• Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation

  2014cited by this paper
• Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.

  2013cited by this paper
• Stress Inducibility of SIRT1 and Its Role in Cytoprotection and Cancer.

  2013cited by this paper
• Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.

  2013cited by this paper
• Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation.

  2013cited by this paper
• Protective effect of berberine on serum glucose levels in non-obese diabetic mice.

  2012cited by this paper
• Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

  2012cited by this paper
• Glucagon and cyclic AMP: time to turn the page?

  2012cited by this paper
• Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP

  2012cited by this paper
• Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

  2011cited by this paper
• Genetics. Aging genes: the sirtuin story unravels.

  2011cited by this paper
• The role of dysregulated glucagon secretion in type 2 diabetes

  2011cited by this paper
• SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.

  2011cited by this paper
• Regulation of Cellular Metabolism by Protein Lysine Acetylation

  2010cited by this paper
• Glucagon increases hepatic mRNA concentrations of ureagenic and gluconeogenic enzymes in early-lactation dairy cows.

  2009cited by this paper
• SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation

  2009cited by this paper
• AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives

  2009cited by this paper
• Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis.

  2009cited by this paper
• Recent progress in the biology and physiology of sirtuins

  2009cited by this paper
• Glyceroneogenesis Is the Dominant Pathway for Triglyceride Glycerol Synthesis in Vivo in the Rat*

  2008cited by this paper
• A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis

  2008cited by this paper
• Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation

  2007cited by this paper
• Berberine stimulates glucose transport through a mechanism distinct from insulin.

  2007cited by this paper
• Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States

  2006cited by this paper
• Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine Published, JLR Papers in Press, February 28, 2006.

  2006cited by this paper
• Unlocking the secrets of longevity genes

  2006cited by this paper
• Unlocking the secrets of longevity genes.

  2006cited by this paper
• Factors That Control the Tissue-Specific Transcription of the Gene for Phosphoenolpyruvate Carboxykinase-C

  2005cited by this paper
• Glucagon and regulation of glucose metabolism.

  2003cited by this paper
• Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver

  2002cited by this paper
• Glucose metabolism in mouse embryos exposed to metformin in vitro.

  1999cited by this paper
• Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme.

  1994cited by this paper
• Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging

  1992cited by this paper
• Ammonia metabolism.

  1978cited by this paper
• HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS

  1969cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• Pharmacological properties and therapeutic potential of berberine: a comprehensive review

  2025cites this paper
• A Narrative Review on Plant Extracts for Metabolic Syndrome: Efficacy, Safety, and Technological Advances

  2025cites this paper
• Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms

  2025cites this paper
• Search for acetylcholinesterase inhibitors by computerized screening of approved drug compounds

  2025cites this paper
• The role of AMPK signaling pathway in the pathogenesis of type 2 diabetes mellitus with its complications and related metabolic disorders

  2025cites this paper
• Biochemical changes associated with non-alcoholic fatty liver disease in response to berberine treatment: a systematic review and meta-analysis of clinical and preclinical research

  2025cites this paper
• Effects of Berberis asiatica, Withania somnifera, and Their Combination on Body Weight in Streptozotocin-Nicotinamide-Induced Type 2 Diabetes in Wistar Rats

  2024cites this paper
• Natural Products as Pharmacological Modulators of Mitochondrial Dysfunctions for the Treatment of Diabetes and Its Complications: An update since 2010.

  2024cites this paper
• Inhibition of CFTR-mediated intestinal chloride secretion by nornidulin: Cellular mechanisms and anti-secretory efficacy in human intestinal epithelial cells and human colonoids

  2024cites this paper
• Berberine Induces Mitophagy through Adenosine Monophosphate-Activated Protein Kinase and Ameliorates Mitochondrial Dysfunction in PINK1 Knockout Mouse Embryonic Fibroblasts

  2023cites this paper
• Addressing the preventive and therapeutic perspective of berberine against diabetes

  2023cites this paper
• Advances in natural small molecules on pretranslational regulation of gluconeogenesis

  2023cites this paper
• A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant

  2023cites this paper
• Berberine: Pharmacological features in health, disease and aging.

  2023cites this paper
• Berberine—A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women

  2023cites this paper
• Berberine inhibits gluconeogenesis in spontaneous diabetic rats by regulating the AKT/MAPK/NO/cGMP/PKG signaling pathway

  2023cites this paper
• Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors

  2023cites this paper
• The mechanism of berberine alleviating metabolic disorder based on gut microbiome

  2022cites this paper
• Research progress on the pharmacological effects of berberine targeting mitochondria

  2022cites this paper
• Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage

  2022cites this paper
• NAD+ Homeostasis in Diabetic Kidney Disease

  2021cites this paper
• SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice

  2021cites this paper
• Berberine Regulated miR150-5p to Inhibit P2X7 Receptor, EMMPRIN and MMP-9 Expression in oxLDL Induced Macrophages

  2021cites this paper
• Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system

  2021cites this paper
• Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment

  2021cites this paper
• WJCPR11 reverses the TNF-α-induced inhibition of adipocyte differentiation and glucose uptake.

  2021cites this paper
• Dietary Bioactive Ingredients Modulating the cAMP Signaling in Diabetes Treatment

  2021cites this paper
• Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine.

  2021cites this paper
• The Mechanism of Jinqi Jiangtang Tablet in Treatment of Type 2 Diabetes Mellitus Based on Network Pharmacology

  2020cites this paper
• Effects of Berberine on Development in Caenorhabditis elegans

  2020cites this paper
• Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases

  2020cites this paper
• A protocol for systematic review and meta-analysis

  2020cites this paper
• Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.

  2020cites this paper
• Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice

  2020cites this paper
• To assess the effective and safety of berberine hydrochloride in ulcerative colitis

  2020cites this paper
• Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis.

  2020cites this paper
• Dietary berberine regulates lipid metabolism in muscle and liver of black sea bream (Acanthopagrus schlegelii) fed normal or high-lipid diets

  2020cites this paper
• Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo—A Preliminary Study

  2020cites this paper
• Effects of berberine supplementation in high starch diet on growth performance, antioxidative status, immune parameters and ammonia stress response of fingerling black sea bream (Acanthopagrus schlegelii)

  2020cites this paper
• Metformin and Berberine suppress glycogenolysis by inhibiting glycogen phosphorylase and stabilizing the molecular structure of glycogen in db/db mice.

  2020cites this paper
• Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function.

  2020cites this paper
• Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics

  2019cites this paper
• Berberine increases glucose uptake and intracellular ROS levels by promoting Sirtuin 3 ubiquitination.

  2019cites this paper
• Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review

  2019cites this paper
• Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives.

  2019cites this paper